https://www.eventsnewsasia.com/2026060905271800032269-u-s-polo-assn-returns-to-downtown-london-as-official-apparel-and-jersey-partner-of-chestertons-polo-in-the-park/ EventsNewsAsia.com en 2026-06-09T20:36:13+08:00 U.S. Polo Assn. Returns to Downtown London as Official Apparel and Jersey Partner of Chestertons Polo in the Park https://www.eventsnewsasia.com/2026060905271800032264-haven-safety-ai-announces-product-availability-in-australia-marking-first-international-expansion/ EventsNewsAsia.com en 2026-06-09T19:55:30+08:00 Haven Safety AI Announces Product Availability in Australia, Marking First International Expansion https://www.eventsnewsasia.com/2026060905271800032274-doubleview-reports-assays-from-drill-holes-h102-h108-extends-hat-mineralization-approximately-150m-east-and-identifies-gold-enriched-intervals/ EventsNewsAsia.com en 2026-06-09T18:07:32+08:00 Doubleview Reports Assays from Drill Holes H102-H108, Extends Hat Mineralization Approximately 150m East and Identifies Gold-Enriched Intervals https://www.eventsnewsasia.com/2026060905271800032276-everest-medicines-secures-exclusive-license-for-sumecigrel-in-asia-pacific-expanding-its-cardiovascular-product-portfolio/ EventsNewsAsia.com en 2026-06-09T14:10:47+08:00 Everest Medicines Secures Exclusive License for Sumecigrel in Asia-Pacific, Expanding Its Cardiovascular Product Portfolio https://www.eventsnewsasia.com/2026060905271800032271-slovak-japanese-animated-film-angel-meow-wins-prestigious-crystal-pine-award-decided-by-an-oscar-and-bafta-winning-jury/ EventsNewsAsia.com en 2026-06-09T08:47:11+08:00 Slovak-Japanese Animated Film “Angel & Meow” Wins Prestigious Crystal Pine Award, Decided by an Oscar and BAFTA-Winning Jury https://www.eventsnewsasia.com/2026060905271800032261-ga-asi-announces-investments-in-six-dutch-companies/ EventsNewsAsia.com en 2026-06-09T01:00:18+08:00 GA-ASI Announces Investments in Six Dutch Companies https://www.eventsnewsasia.com/2026060805271800032256-cmss-867-hk-8a8-sg-self-developed-innovative-inhbe-targeting-sirna-drug-cms-d008-presents-its-preclinical-results-at-the-ada-scientific-sessions/ EventsNewsAsia.com en 2026-06-08T19:41:00+08:00 CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions